文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

呼气肌活动抵消呼气末正压并与芬太尼剂量相关:ARDS患者研究

Expiratory Muscle Activity Counteracts Positive End-Expiratory Pressure and Is Associated with Fentanyl Dose in Patients with Acute Respiratory Distress Syndrome.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01
一句话结论半数ARDS患者使用神经肌肉阻滞剂后呼气末肺阻抗增加>10%潮气量,提示呼气肌活动抵消PEEP,且与芬太尼剂量呈剂量-反应关系。

本研究在2个中心纳入46例接受神经肌肉阻滞剂(NMBA)的机械通气ARDS患者,用电阻抗断层成像(EIT)监测呼气末肺阻抗(EELI,呼气末肺容积的替代指标)变化。结果显示46.2%的患者在NMBA后EELI增加超过对应潮气量的10%(IQR 23.9-60.9%),EELI增加程度与芬太尼剂量正相关、与呼气末胸膜压变化负相关。另在10例患者中同步用EIT和食管导管验证了呼气肌活动的特征信号。作者认为呼气肌活动可能对PEEP产生强烈对抗效应,芬太尼可能加重这一效应,提示保护性通气期间芬太尼的潜在副作用。

要点

  • 46例机械通气ARDS患者中46.2%在给予NMBA后EELI增加>10%对应潮气量(IQR 23.9-60.9%),提示呼气肌活动普遍存在。
  • EELI增加程度与芬太尼剂量呈正相关,提示芬太尼可能加重呼气肌对PEEP的对抗效应。
  • EELI增加程度与呼气末胸膜压变化呈负相关,支持呼气肌活动抵消PEEP的机制。
  • 另10例患者同步EIT与食管导管监测,验证了呼气肌活动的特征性EIT信号。
  • 作者认为这提示保护性通气期间芬太尼的潜在副作用,呼气肌活动可能通过肺塌陷降低呼气末肺容积而加重低氧血症。

适用人群与场景

  • 2个中心接受机械通气并给予神经肌肉阻滞剂(NMBA)的ARDS患者,共46例;另纳入10例同步行EIT与食管导管监测以验证呼气肌活动特征信号。

诊断标准与关键阈值

  • EELI增加>10%对应潮气量(Vt)定义为存在呼气肌活动相关EELI增加,发生率为46.2%(IQR 23.9-60.9%)。

研究设计与关键结果

  • 研究类型:在2个中心开展的研究,纳入46例机械通气ARDS患者,用EIT监测NMBA给药前后EELI变化(呼气末肺容积替代指标)。
  • 主要结果:46.2%的患者NMBA后EELI增加>10%对应Vt(IQR 23.9-60.9%)。
  • EELI增加程度与芬太尼剂量呈正相关,与呼气末胸膜压变化呈负相关。
  • 另10例患者同步EIT与食管导管监测,显示呼气肌活动的特征性信号。

证据类型、等级与局限

  • 证据类型:在2个中心开展的临床研究(EIT监测研究),另含10例同步食管压监测的生理学验证。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为:ARDS保护性通气期间芬太尼可能存在潜在副作用,即加重呼气肌活动对PEEP的对抗;EIT监测可揭示NMBA给药后呼气肌活动的存在及其对呼气末肺容积的影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Rationale: Hypoxemia during mechanical ventilation might be worsened by expiratory muscle activity, which reduces end-expiratory lung volume through lung collapse. A proposed mechanism of benefit of neuromuscular blockade in acute respiratory distress syndrome (ARDS) is the abolition of expiratory efforts. This may contribute to the restoration of lung volumes. The prevalence of this phenomenon, however, is unknown. Objectives: To investigate the incidence and amount of end-expiratory lung impedance (EELI) increase after the administration of neuromuscular blocking agents (NMBAs), clinical factors associated with this phenomenon, its impact on regional lung ventilation, and any association with changes in pleural pressure. Methods: We included mechanically ventilated patients with ARDS monitored with electrical impedance tomography (EIT) who received NMBAs in one of two centers. We measured changes in EELI, a surrogate for end-expiratory lung volume, before and after NMBA administration. In an additional 10 patients, we investigated the characteristic signatures of expiratory muscle activity depicted by EIT and esophageal catheters simultaneously. Clinical factors associated with EELI changes were assessed. Measurements and Main Results: We included 46 patients, half of whom showed an increase in EELI of >10% of the corresponding Vt (46.2%; IQR, 23.9-60.9%). The degree of EELI increase correlated positively with fentanyl dosage and negatively with changes in end-expiratory pleural pressures. This suggests that expiratory muscle activity might exert strong counter-effects against positive end-expiratory pressure that are possibly aggravated by fentanyl. Conclusions: Administration of NMBAs during EIT monitoring revealed activity of expiratory muscles in half of patients with ARDS. The resultant increase in EELI had a dose-response relationship with fentanyl dosage. This suggests a potential side effect of fentanyl during protective ventilation.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Plens GM, Droghi MT, Alcala GC, et al. Expiratory Muscle Activity Counteracts Positive End-Expiratory Pressure and Is Associated with Fentanyl Dose in Patients with Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2024. PMID: 38190718. doi:10.1164/rccm.202308-1376OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。